| |
|
|
|
|
|
ACULAR LS® is a non-steroidal anti-inflammatory (NSAID) indicated to reduce pain, burning and stinging following corneal refractive surgery. Approved by the U.S. Food and Drug Administration in 2003, the optimized 0.4 percent formulation of ACULAR LS® is clinically proven to block the source of post-corneal refractive surgical eye pain. ACULAR LS® has been shown to achieve significant and rapid pain relief.2
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
AK-Pentolate™ (cyclopentolate hydrochloride ophthalmic solution, USP)
|
Company:
Date:
June 29, 2009
|
|
|
|
|
|
|
|
|
|
ALAMAST® is an eyedrop (available by prescription only) that is used to prevent itchy eyes caused by allergies.
LAMAST® works so you can quickly return to your daily routine. ALAMAST® provides rapid relief of itching with almost no burning or stinging of the eyes. In fact, ALAMAST® is gentile enough to use in patients as young as 3 years of age.
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
ALOCRIL®, approved by the U.S. Food and Drug Administration in 1999, is a prescription eye drop for itchy allergy eyes. An estimated 50 million Americans suffer from all types of allergies, and an estimated 4 percent of all allergy sufferers have eye allergies as their primary allergy.1
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
ALOCRIL®, approved by the U.S. Food and Drug Administration in 1999, is a prescription eye drop for itchy allergy eyes. An estimated 50 million Americans suffer from all types of allergies, and an estimated 4 percent of all allergy sufferers have eye allergies as their primary allergy.1
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
ALPHAGAN® P 0.1, approved by the U.S. Food and Drug Administration (FDA) in 2005, and ALPHAGAN® P 0.15, approved by the FDA in 2001, are indicated to lower IOP in patients with open-angle glaucoma and ocular hypertension. They are improved formulations of ALPHAGAN® developed to further minimize drug exposure while maintaining the drug's favorable efficacy profile.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
The first corticosteroid specifically designed for seasonal allergic conjunctivitis, Alrex® offers powerful relief against the whole symptom complex, i.e., itching, redness, burning, and photophobia.
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
Aminoglycosides are used for serious gram-negative infections, especially Pseudomonas aeruginosa. They are active against most gram-negative aerobic bacilli but lack activity against anaerobes and most gram-positive bacteria, except for most staphylococci; however, some gram-negative bacilli and methicillin-resistant staphylococci are resistant.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
Aminoglycosides are used for serious gram-negative infections, especially Pseudomonas aeruginosa. They are active against most gram-negative aerobic bacilli but lack activity against anaerobes and most gram-positive bacteria, except for most staphylococci; however, some gram-negative bacilli and methicillin-resistant staphylococci are resistant.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
AZOPT® Ophthalmic suspension (brinzolamide ophthalmic suspension 1) is used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
|
Company:
Date:
April 22, 2009
|
|
|
|
|
|